Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 7.10 is 63% above its 5-year average of 4.36, near the high end of its 5-year range (0.64–9.17).
As of the fiscal period ended Tuesday, June 30, 2026. 161.95% above its 12-month average of 2.71.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 7.10.
QUICK RATIO (ACID-TEST)
7.10
QUICK RATIO (ACID-TEST) AVG TTM
2.71
QUICK RATIO (ACID-TEST) AVG 3Y
3.30
QUICK RATIO (ACID-TEST) AVG 5Y
4.36
QUICK RATIO (ACID-TEST) AVG 10Y
3.68
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+161.95%
CURRENT VS 3Y AVG
+115.48%
CURRENT VS 5Y AVG
+62.93%
CURRENT VS 10Y AVG
+93.12%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.28
median of 797 covered companies
CURRENT VS SECTOR MEDIAN
+116.55%
vs the sector median at left
ENDRA Life Sciences Inc.
Market Cap
$7.95M
Quick Ratio (Acid-Test)
7.10
TTM Avg
2.71
3Y Avg
3.30
5Y Avg
4.36
Market Cap
$7.96M
Quick Ratio (Acid-Test)
5.86
TTM Avg
2.71
3Y Avg
2.06
5Y Avg
3.31
Market Cap
$7.97M
Quick Ratio (Acid-Test)
2.61
TTM Avg
2.11
3Y Avg
2.42
5Y Avg
2.17
Market Cap
$7.99M
Quick Ratio (Acid-Test)
13.55
TTM Avg
6.32
3Y Avg
6.80
5Y Avg
6.83
Market Cap
$7.66M
Quick Ratio (Acid-Test)
14.52
TTM Avg
3.29
3Y Avg
11.30
5Y Avg
10.20
Market Cap
$8.25M
Quick Ratio (Acid-Test)
-71.42
TTM Avg
0.41
3Y Avg
1.44
5Y Avg
1.15
Market Cap
$7.40M
Quick Ratio (Acid-Test)
0.95
TTM Avg
9.81
3Y Avg
5.30
5Y Avg
4.51
Market Cap
$8.50M
Quick Ratio (Acid-Test)
0.60
TTM Avg
0.62
3Y Avg
0.79
5Y Avg
1.04
Market Cap
$8.53M
Quick Ratio (Acid-Test)
0.10
TTM Avg
0.10
3Y Avg
0.10
5Y Avg
0.10
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | $7.95M | 7.10 | 2.71 | 3.30 | 4.36 |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.96M | 5.86 | 2.71 | 2.06 | 3.31 |
| GT Biopharma, Inc. (GTBP)vs › | $7.97M | 2.61 | 2.11 | 2.42 | 2.17 |
| Aprea Therapeutics, Inc. (APRE)vs › | $7.99M | 13.55 | 6.32 | 6.80 | 6.83 |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.66M | 14.52 | 3.29 | 11.30 | 10.20 |
| HeartSciences Inc. (HSCS)vs › | $8.25M | -71.42 | 0.41 | 1.44 | 1.15 |
| Skye Bioscience, Inc. (SKYE)vs › | $7.40M | 0.95 | 9.81 | 5.30 | 4.51 |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.50M | 0.60 | 0.62 | 0.79 | 1.04 |
| DataMEDS AI, Inc. (MEDS)vs › | $8.53M | 0.10 | 0.10 | 0.10 | 0.10 |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | 1.37 | 3.92 | 4.12 | 3.73 |
Quick Ratio
7.10
Excludes inventory
Current Ratio
7.10
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 7.10 |
| 2026-03-31 | 0.64 |
| 2025-12-31 | 1.29 |
| 2025-09-30 | 1.31 |
| 2025-06-30 | 3.21 |
| 2025-03-31 | 3.85 |
| 2024-12-31 | 5.67 |
| 2024-09-30 | 6.10 |
| 2024-06-30 | 4.97 |
| 2024-03-31 | 1.04 |
| 2023-12-31 | 3.36 |
| 2023-09-30 | 1.68 |
| 2023-06-30 | 2.62 |
| 2023-03-31 | 1.52 |
| 2022-12-31 | 3.45 |
| 2022-09-30 | 5.24 |
| 2022-06-30 | 8.06 |
| 2022-03-31 | 6.03 |
| 2021-12-31 | 7.00 |
| 2021-09-30 | 8.23 |
| 2021-06-30 | 9.17 |
| 2021-03-31 | 23.01 |
| 2020-12-31 | 7.72 |
| 2020-09-30 | 3.19 |
| 2020-06-30 | 1.56 |
| 2020-03-31 | 2.32 |
| 2019-12-31 | 3.10 |
| 2019-09-30 | 1.54 |
| 2019-06-30 | 2.11 |
| 2019-03-31 | 5.15 |
| 2018-12-31 | 7.07 |
| 2018-09-30 | 0.38 |
| 2018-06-30 | 2.31 |
| 2018-03-31 | 3.74 |
| 2017-12-31 | 6.71 |
| 2017-09-30 | 22.72 |
| 2017-06-30 | 46.45 |
| 2017-03-31 | 0.12 |
| 2016-12-31 | 0.11 |
| 2016-09-30 | 0.09 |
| 2016-06-30 | 0.99 |
| 2016-03-31 | 0.00 |
| 2015-12-31 | 0.12 |
| 2015-09-30 | 0.00 |
| 2015-06-30 | 0.00 |
| 2015-03-31 | 0.00 |
